iDD biotech

iDD biotech  est membre de Lyonbiopôle

General information

Bâtiment Accinov / 317 avenue Jean-Jaures

69007 Lyon

Incorporated in: 2008/05/14

Number of employees: 9

Turnover: €4M (in 2016)

More information


Main activity

    iDD biotech is a biopharmaceutical company focused on developing innovative products in targeted immunotherapy, based upon monoclonal antibodies, for the treatment of cancer, autoimmune diseases and inflammation. The company is aiming at reinforcing the therapeutic arsenal and the pipeline of pharmaceutical companies.


Looking for funding: Yes

Nature of funding searches: We are looking for the a 14 €m A series to lead 2 oncology MABs to clinical.

Private funding obtained: In progress

Public funding obtained: Financial FUI support: PRAVIC (537 k€), GLIADYS (1 474 k€), ACILIMAB (592 k€), CLARA IPROMAH (250 k€), CLARA THERA8 (300 k€)      

Stock exchange listing: Not applicable

Products / Services / Technologies
Partnership opportunities / Licensing

Strategic area of application
Human Medicine

Application market
Immune, AutoIm & Inflam. diseases - Oncology

Therapeutics, Pharma or Biotech

Nanotechnology - Antibodies - Protein - Peptide